Chat Politics column Published 24th September 2014 http://www.chatpolitics.org/nuclear-weapons-just-wooly-issue/ It was peace that first brought Molly into politics when she was 16 and founded Bath Youth CND. Now, some 30 years later as a newly elected MEP, she again finds herself championing the anti nuclear cause. Not just at wonderful events like Wool Against Weapons but … Read moreNuclear weapons: not just a wooly issue
Huffington Post blog Published 10th Sept 2014 http://www.huffingtonpost.co.uk/molly-scott-cato/politics-business_b_5789824.html Molly writing with her Green colleague Sven Giegold who both sit on the European Parliament’s Economics and Monetary Affairs Committee (ECON). Using the example of Sharon Bowles, ex-chair of ECON who has taken up a directorship at the London Stock Exchange, this article explores how politicians damage … Read moreBrussels Revolving Door Leads Straight to the City
New Internationalist blog Published August 22, 2014 http://newint.org/blog/2014/08/22/europe-azerbaijan/#sthash.jm9sXVw6.dpuf Molly offers a fresh insight into one of Europe’s least known and understood countries: Azerbaijan. Based on work with one of her constituents in the South West she explores how human rights abuses by the Azerbaijani government are impacting on people’s lives, particularly those working in civil … Read moreWhat lies behind Europe’s murky oil deals with Azerbaijan?
Huffington Post blog Published 22nd July 2014 http://www.huffingtonpost.co.uk/molly-scott-cato/the-sweet-drug-of-bank-su_b_5605867.html Written with her Green colleagues in the European Parliament: Bas Eickhout (Netherlands), Sven Giegold (Germany), Eva Joly (France), Philippe Lamberts (Belgium), and Ernest Urtasun (Spain). The article looks at the dominance of large banks in the financial services sector and how they would be making heavy losses … Read moreThe Sweet Drug of Bank Subsidies
Guardian: Comment is Free Published 23rd April 2014 http://www.theguardian.com/commentisfree/2014/apr/23/reason-drugs-cost-so-much-big-pharmaceuticals-rich Molly explores how the lack of a free market makes drugs very expensive, and increasing market consolidation will only exacerbate the problem still further.